BamSEC and AlphaSense Join Forces
Learn More

Tango Therapeutics Inc. – Indentures

NASDAQ: TNGX    
Share price (6/23/26): $28.39    
Market cap (6/23/26): $4.107 billion

Indentures Filter

EX-4.1
from 8-K 12 pages Tango Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.6
from S-3ASR 40 pages Tango Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Subordinated Debt Securities
12/34/56
EX-4.5
from S-3ASR 39 pages Tango Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Senior Debt Securities
12/34/56
EX-4.1
from 8-K 11 pages Tango Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.6
from S-3 40 pages Tango Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Subordinated Debt Securities
12/34/56
EX-4.5
from S-3 39 pages Tango Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Senior Debt Securities
12/34/56
EX-4.1
from 8-K 11 pages Tango Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4
from 10-K 5 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from S-3 40 pages Tango Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [●], 202[●] Subordinated Debt Securities
12/34/56
EX-4.5
from S-3 39 pages Tango Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [●], 202[●] Senior Debt Securities
12/34/56
EX-4.2
from 10-K 5 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from S-8 23 pages Amended and Restated By-Laws of BCTG Acquisition Corp
12/34/56
EX-4.5
from S-4/A 3 pages Tango Therapeutics, Inc. Common Stock
12/34/56
EX-4.1
from S-1/A 2 pages BCTG Acquisition Corp. Incorporated Under the Laws of the State of Delaware Common Stock
12/34/56